Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0((c)). Neurogastroenterol Motil. 2021;33(1):e14058. https://doi.org/10.1111/nmo.14058.
Article PubMed PubMed Central Google Scholar
Sonnenberg A. Hospitalization for achalasia in the United States 1997–2006. Dig Dis Sci. 2009;54(8):1680–5. https://doi.org/10.1007/s10620-009-0863-8.
Gennaro N, Portale G, Gallo C, et al. Esophageal achalasia in the Veneto region: epidemiology and treatment. Epidemiology and treatment of achalasia. J Gastrointest Surg. 2011;15(3):423–8. https://doi.org/10.1007/s11605-010-1392-7.
Mari A, Sbeit W, Abboud W, Awadie H, Khoury T. Achalasia in the elderly: diagnostic approach and a proposed treatment algorithm based on a comprehensive literature review. J Clin Med. 2021. https://doi.org/10.3390/jcm10235565.
Article PubMed PubMed Central Google Scholar
Kim DH, Jung H-Y. The long-term outcome of balloon dilation versus botulinum toxin injection in patients with primary achalasia. Korean J Intern Med. 2014;29(6):727–9. https://doi.org/10.3904/kjim.2014.29.6.727.
Article PubMed PubMed Central Google Scholar
Zhao H, Wan XJ, Yang CQ. Comparison of endoscopic balloon dilation with metal stent placement in the treatment of achalasia. J Dig Dis. 2015;16(6):311–8. https://doi.org/10.1111/1751-2980.12241.
Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42(4):265–71. https://doi.org/10.1055/s-0029-1244080.
Article CAS PubMed Google Scholar
Okada H, Shiwaku H, Ohmiya T, Shiwaku A, Hasegawa S. Efficacy and safety of peroral endoscopic myotomy in 100 older patients. Esophagus. 2021. https://doi.org/10.1007/s10388-021-00881-7.
Article PubMed PubMed Central Google Scholar
Ujiie N, Sato C, Taniyama Y, et al. Characteristics of esophageal achalasia in geriatric patients over 75 years of age and outcomes after peroral endoscopic myotomy. Geriatr Gerontol Int. 2021;21(9):788–93. https://doi.org/10.1111/ggi.14235.
Liu XY, Cheng J, Chen WF, et al. Effect of peroral endoscopic myotomy in geriatric patients: a propensity score matching study. Surg Endosc. 2020;34(7):2911–7. https://doi.org/10.1007/s00464-019-07070-9.
Sanaka MR, Chadalavada P, Alomari M, et al. Peroral endoscopic myotomy is a safe and effective treatment modality for geriatric patients with achalasia. Esophagus. 2020;17(4):484–91. https://doi.org/10.1007/s10388-020-00746-5.
Li C-J, Tan Y-Y, Wang X-H, Liu D-L. Peroral endoscopic myotomy for achalasia in patients aged≥ 65 years. World J Gastroenterol. 2015;21(30):9175–81. https://doi.org/10.3748/wjg.v21.i30.9175.
Article PubMed PubMed Central Google Scholar
Wang X, Tan Y, Lv L, et al. Peroral endoscopic myotomy versus pneumatic dilation for achalasia in patients aged ≥ 65 years. Rev Esp Enferm Dig. 2016;108(10):637–41. https://doi.org/10.17235/reed.2016.4488/2016.
Abe H, Tanaka S, Kawara F, et al. Comparison of the safety and efficacy of peroral endoscopic myotomy between octogenarians and non-octogenarians. Dig Endosc. 2021;33(1):110–7. https://doi.org/10.1111/den.13686.
Chen Y-I, Inoue H, Ujiki M, et al. An international multicenter study evaluating the clinical efficacy and safety of per-oral endoscopic myotomy in octogenarians. Gastrointest Endosc. 2018;87(4):956–61. https://doi.org/10.1016/j.gie.2017.02.007.
McKay SC, Dunst CM, Sharata AM, et al. POEM: clinical outcomes beyond 5 years. Surg Endosc. 2021;35(10):5709–16. https://doi.org/10.1007/s00464-020-08031-3.
Khashab MA, Vela MF, Thosani N, et al. ASGE guideline on the management of achalasia. Gastrointest Endosc. 2020;91(2):213-227 e6. https://doi.org/10.1016/j.gie.2019.04.231.
Bechara R, Ikeda H, Inoue H. Peroral endoscopic myotomy: an evolving treatment for achalasia. Nat Rev Gastroenterol Hepatol. 2015;12(7):410–26. https://doi.org/10.1038/nrgastro.2015.87.
Nabi Z, Reddy DN, Ramchandani M. Adverse events during and after per-oral endoscopic myotomy: prevention, diagnosis, and management. Gastrointest Endosc. 2018;87(1):4–17. https://doi.org/10.1016/j.gie.2017.09.029.
Urbach DR, Tomlinson GA, Harnish JL, Martino R, Diamant NE. A measure of disease-specific health-related quality of life for achalasia. Am J Gastroenterol. 2005;100(8):1668–76. https://doi.org/10.1111/j.1572-0241.2005.50141.x.
Jonasson C, Wernersson B, Hoff DA, Hatlebakk JG. Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2013;37(5):564–72. https://doi.org/10.1111/apt.12204.
Article CAS PubMed Google Scholar
Vaezi MF, Pandolfino JE, Yadlapati RH, Greer KB, Kavitt RT. ACG clinical guidelines: diagnosis and management of achalasia. Am J Gastroenterol. 2020;115(9):1393–411. https://doi.org/10.14309/ajg.0000000000000731.
Article PubMed PubMed Central Google Scholar
Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2009;30(10):1030–8. https://doi.org/10.1111/j.1365-2036.2009.04142.x.
Article CAS PubMed Google Scholar
Tang X, Ren Y, Gao Q, et al. Peroral endoscopic myotomy is safe and effective in achalasia patients aged older than 60 years compared with younger patients. Geriatr Gerontol Int. 2017;17(12):2407–13. https://doi.org/10.1111/ggi.13083.
Ujiie N, Sato H, Fujiyoshi MRA, et al. Geriatric patients with esophageal motility disorders benefit more from minimally invasive peroral endoscopic myotomy: a multicenter study in Japan. Dis Esophagus. 2021. https://doi.org/10.1093/dote/doab086.
Teitelbaum EN, Dunst CM, Reavis KM, et al. Clinical outcomes five years after POEM for treatment of primary esophageal motility disorders. Surg Endosc. 2018;32(1):421–7. https://doi.org/10.1007/s00464-017-5699-2.
AbiMansour JP, Ichkhanian Y, Minami H, et al. Durability of per-oral endoscopic myotomy beyond 6 years. Endosc Int Open. 2021;9(11):E1595–601. https://doi.org/10.1055/a-1553-9846.
Article PubMed PubMed Central Google Scholar
Peng D, Tan Y, Li C, et al. Peroral endoscopic myotomy for pediatric achalasia: a retrospective analysis of 21 cases with a minimum follow-up of 5 years. Original research. Front Pediatr. 2022. https://doi.org/10.3389/fped.2022.845103.
Article PubMed PubMed Central Google Scholar
Kurian AA, Dunst CM, Sharata A, Bhayani NH, Reavis KM, Swanström LL. Peroral endoscopic esophageal myotomy: defining the learning curve. Gastrointest Endosc. 2013;77(5):719–25. https://doi.org/10.1016/j.gie.2012.12.006.
Liu Z, Zhang X, Zhang W, et al. Comprehensive evaluation of the learning curve for peroral endoscopic myotomy. Clin Gastroenterol Hepatol Off Clin Prac J Am Gastroenterol Assoc. 2018. https://doi.org/10.1016/j.cgh.2017.11.048.
Li QL, Wu QN, Zhang XC, et al. Outcomes of per-oral endoscopic myotomy for treatment of esophageal achalasia with a median follow-up of 49 months. Gastrointest Endosc. 2018;87(6):1405-1412 e3. https://doi.org/10.1016/j.gie.2017.10.031.
Liu ZQ, Li QL, Chen WF, et al. The effect of prior treatment on clinical outcomes in patients with achalasia undergoing peroral endoscopic myotomy. Endoscopy. 2019;51(4):307–16. https://doi.org/10.1055/a-0658-5783.
Article CAS PubMed Google Scholar
Ren Y, Tang X, Chen Y, et al. Pre-treatment Eckardt score is a simple factor for predicting one-year peroral endoscopic myotomy failure in patients with achalasia. Surg Endosc. 2017;31(8):3234–41. https://doi.org/10.1007/s00464-016-5352-5.
Yeniova AO, Yoo IK, Jeong E, Cho JY. Comparison of peroral endoscopic myotomy between de-novo achalasia and achalasia with prior treatment. Surg Endosc. 2021;35(1):200–8. https://doi.org/10.1007/s00464-020-07380-3.
Nabi Z, Ramchandani M, Chavan R, et al. Peroral endoscopic myotomy in treatment-naïve achalasia patients versus prior treatment failure cases. Endoscopy. 2018;50(4):358–70. https://doi.org/10.1055/s-0043-121632.
Li Q-L, Yao L-Q, Xu X-Y, et al. Repeat peroral endoscopic myotomy: a salvage option for persistent/recurrent symptoms. Endoscopy. 2016;48(2):134–40. https://doi.org/10.1055/s-0034-1393095.
Comments (0)